ELIZABETH MUIJE: Open Payments
NPI 1851433031 · BLUFFDALE, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$326 in 14 payments from 8 companies in 2025. Trend: 2023 $265 · 2024 $336 · 2025 $326
Food & beverage: $326
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 5 | $116 |
| Hologic Sales and Service, LLC | 2 | $49 |
| Baxter Healthcare | 1 | $47 |
| SHIELD THERAPEUTICS INC | 2 | $37 |
| ABBVIE INC. | 1 | $25 |
| Biogen, Inc. | 1 | $22 |
| Sumitomo Pharma America, Inc. | 1 | $15 |
| Organon LLC | 1 | $14 |
Products named: Veozah, PERCLOT, ACCRUFER, NOVASURE, QULIPTA, ZURZUVAE, APTIMA, MYFEMBREE.
Industry payments across UT — which companies pay providers there.
